A Systematic Review of Focal Cartilage Defect Treatments in Middle-Aged Versus Younger Patients

Abstract

Background: Focal cartilage defects are often debilitating, possess limited potential for regeneration, are associated with increased risk of osteoarthritis, and are predictive for total knee arthroplasty. Cartilage repair studies typically focus on the outcome in younger patients, but a high proportion of treated patients are 40 to 60 years of age (ie, middle-aged). The reality of current clinical practice is that the ideal patient for cartilage repair is not the typical patient. Specific attention to cartilage repair outcomes in middle-aged patients is warranted. Purpose: To systematically review available literature on knee cartilage repair in middle-aged patients and include studies comparing results across different age groups. Study Design: Systematic review; Level of evidence, 4. Methods: A systematic search was performed in EMBASE, MEDLINE, and the Cochrane Library database. Articles were screened for relevance and appraised for quality. Results: A total of 21 articles (mean Coleman Methodology Score, 64 points) were included. Two out of 3 bone marrow stimulation (BMS) studies, including 1 using the microfracture technique, revealed inferior clinical outcomes in middle-aged patients in comparison with younger patients. Nine cell-based studies were included showing inconsistent comparisons of results across age groups for autologous chondrocyte implantation (ACI). Bone marrow aspirate concentrate showed age-independent results at up to 8 years of follow-up. A negative effect of middle age was reported in 1 study for both ACI and BMS. Four out of 5 studies on bone-based resurfacing therapies (allografting and focal knee resurfacing implants [FKRIs]) showed age-independent results up to 5 years. One study in only middle-aged patients reported better clinical outcomes for FKRIs when compared with biological repairs. Conclusion: Included studies were heterogeneous and had low methodological quality. BMS in middle-aged patients seems to only result in short-term improvements. More research is warranted to elucidate the ameliorating effects of cell-based therapies on the aging joint homeostasis. Bone-based therapies seem to be relatively insensitive to aging and may potentially result in effective joint preservation. Age subanalyses in cohort studies, randomized clinical trials, and international registries should generate more evidence for the large but underrepresented (in terms of cartilage repair) middle-aged population in the literature.

Patchouli Alcohol Inhibits D-Gal Induced Oxidative Stress and Ameliorates the Quality of Aging Cartilage via Activating the Nrf2/HO-1 Pathway in Mice

“…A decline in physical function is a major manifestation of aging, including reduced athletic capacity due to poor cartilage quality. In fact, the natural decline in cartilage performance with advancing age may be a perplexing phenomenon, and chronic age-related cartilage defects in middle-aged patients are perhaps an expression of early osteoarthritis (OA) [ 37 , 38 ]. It is reported that the largest natural decrease of cartilage quality in normative IKDC data occurred between the ages of 51 and 65 years, followed by the decline between the ages of 35 and 50 years [ 39 ].…”

Super‐Strong Hydrogel Composites Reinforced with PBO Nanofibers for Cartilage Replacement

“…[1,2] Unfortunately, due to its avascular nature and scarce cellular content, articular cartilage lesions have a limited ability to self-repair, often leading to osteoarthritis. [3][4][5] Depending on the severity of the damage, different strategies may be adopted to alleviate debilitating pain and restore mobility, delaying the need for a total joint replacement. [4] When pharmacological treatments and physiotherapy are no longer effective, cartilage restoration techniques can be applied, including microfracture, autologous chondrocyte implantation, and osteochondral autograft/allograft transplantation.…”

Articular Cartilage Regeneration through Bioassembling Spherical Micro-Cartilage Building Blocks

“…The existing treatments for articular cartilage defects include debridement, microfracture, osteochondral autograft transfer, osteochondral allograft, and autologous chondrocyte implantation [ 4 ]. However, these treatments each have limitations and drawbacks.…”